SP2086
Sponsors
Jiangsu HengRui Medicine Co., Ltd.
Conditions
Renal InsufficiencyType 2 Diabetes
Phase 1
The Drug-drug Interaction of SP2086 and Metformin
CompletedNCT02813863
Start: 2015-12-31Updated: 2016-06-27
The Drug-drug Interaction of SP2086 and Valsartan
CompletedNCT02815657
Start: 2013-04-30End: 2014-01-31Updated: 2016-06-28
The Drug-drug Interaction of SP2086 and Simvastatin
CompletedNCT02815722
Start: 2013-07-31End: 2014-05-31Updated: 2016-06-28
SP2086 Pharmacokinetic Study in Renal Insufficiency Patients
CompletedNCT02815774
Start: 2014-06-30End: 2015-01-31Updated: 2016-06-28
The Drug -Drug Interaction of SP2086 and Glyburide
CompletedNCT02815787
Start: 2014-03-31End: 2014-07-31Updated: 2016-06-28
The Metabolite Identification and Material Balance Study of SP2086
CompletedNCT02815748
Start: 2015-08-31End: 2015-10-31Updated: 2016-07-01
The DDI Study of SP2086 and Simvastatin
NCT02817243
Start: 2016-03-31Target: 24Updated: 2016-06-29
The DDI Study of SP2086 and Valsartan
NCT02817217
Start: 2016-03-31Target: 24Updated: 2016-06-29
the Food Effect Pharmacokinetic, Material Balance and Metabolite Identification of SP2086 in Healthy Volunteers
NCT02821871
Start: 2016-03-31End: 2016-09-30Target: 24Updated: 2016-07-04
The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes Patients
NCT02822534
Start: 2016-04-30Target: 24Updated: 2016-07-04
The Pharmacokinetics Study of Single and Multiple Dose of SP2086 in Healthy Volunteers
NCT02826044
Start: 2016-07-31Target: 30Updated: 2016-07-07